会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Polysulfone-based blood treatment membrane and method of producing the same
    • 聚砜类血液处理膜及其制造方法
    • US08220642B2
    • 2012-07-17
    • US12601543
    • 2008-05-26
    • Junya SatohTakahiro IchiShunji Maniwa
    • Junya SatohTakahiro IchiShunji Maniwa
    • B01D69/00B01D69/02B01D67/00
    • B01D71/68A61L33/068B01D67/0011B01D69/141B01D2325/00B01D2325/24C08L81/06
    • A polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties, excellent long-term storage stability, and a practical strength, and ensures high productivity, a polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties and long-term storage stability, rarely allows endotoxins to enter a treatment liquid, exhibits a practical strength, and ensures high productivity, and a method of producing the same. A polysulfone-based blood treatment membrane includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant, the membrane containing the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, and the total amount of the lipophilic antioxidant present on the surface of the membrane being 4 to 25 mg per gram of the membrane. Another polysulfone-based blood treatment membrane contains a lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, wherein the inner surface of the membrane has a TOF-SIMS normalized peak intensity of the lipophilic antioxidant of 1.8.times.10.sup.-4 or more, and the outer surface of the membrane has a TOF-SIMS normalized peak intensity of the lipophilic antioxidant of 2.4.times.10.sup.-4 or more. A method of producing a polysulfone-based blood treatment membrane that includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant includes producing a membrane intermediate that contains the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane intermediate, and heating the membrane intermediate at 100 to 180.degree. C. for 0.1 to 360 minutes in a dry state.
    • 一种聚砜系血液处理膜,其表现出优异的抗氧化性能,优异的长期保存稳定性和实用强度,并且确保高生产率,表现出优异的抗氧化性能和长期保存稳定性的聚砜系血液处理膜,很少 允许内毒素进入处理液,具有实用的强度,并且确保高生产率及其制备方法。 基于聚砜的血液处理膜包括聚砜系树脂,亲水性聚合物和亲脂性抗氧化剂,每克膜含有30〜76mg的亲脂性抗氧化剂的膜和亲脂性的总量 存在于膜表面的抗氧化剂每克膜为4至25mg。
    • 2. 发明申请
    • POLYSULFONE-BASED BLOOD TREATMENT MEMBRANE AND METHOD OF PRODUCING THE SAME
    • 基于聚合物的血液处理膜及其制造方法
    • US20100133170A1
    • 2010-06-03
    • US12601543
    • 2008-05-26
    • Junya SatohTakahiro IchiShunji Maniwa
    • Junya SatohTakahiro IchiShunji Maniwa
    • B01D71/68C08J5/00B29C47/00D04H3/16B01D69/08B01D67/00B01D69/02
    • B01D71/68A61L33/068B01D67/0011B01D69/141B01D2325/00B01D2325/24C08L81/06
    • A polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties, excellent long-term storage stability, and a practical strength, and ensures high productivity, a polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties and long-term storage stability, rarely allows endotoxins to enter a treatment liquid, exhibits a practical strength, and ensures high productivity, and a method of producing the same. A polysulfone-based blood treatment membrane includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant, the membrane containing the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, and the total amount of the lipophilic antioxidant present on the surface of the membrane being 4 to 25 mg per gram of the membrane. Another polysulfone-based blood treatment membrane contains a lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, wherein the inner surface of the membrane has a TOF-SIMS normalized peak intensity of the lipophilic antioxidant of 1.8×10−4 or more, and the outer surface of the membrane has a TOF-SIMS normalized peak intensity of the lipophilic antioxidant of 2.4×10−4 or more. A method of producing a polysulfone-based blood treatment membrane that includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant includes producing a membrane intermediate that contains the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane intermediate, and heating the membrane intermediate at 100 to 180° C. for 0.1 to 360 minutes in a dry state.
    • 一种聚砜系血液处理膜,其表现出优异的抗氧化性能,优异的长期保存稳定性和实用强度,并且确保高生产率,表现出优异的抗氧化性能和长期保存稳定性的聚砜系血液处理膜,很少 允许内毒素进入处理液,具有实用的强度,并且确保高生产率及其制备方法。 基于聚砜的血液处理膜包括聚砜系树脂,亲水性聚合物和亲脂性抗氧化剂,每克膜含有30〜76mg的亲脂性抗氧化剂的膜和亲脂性的总量 存在于膜表面的抗氧化剂每克膜为4至25mg。 另一种基于聚砜的血液处理膜包含每克膜30至76mg的亲脂性抗氧化剂,其中膜的内表面具有1.8×10-4的亲脂性抗氧化剂的TOF-SIMS归一化峰强度 以上,膜的外表面的亲油性抗氧化剂的TOF-SIMS归一化峰强度为2.4×10 -4以上。 包含聚砜系树脂,亲水性聚合物和亲脂性抗氧化剂的聚砜系血液处理膜的制造方法包括:制造含有亲油性抗氧化剂的膜中间体,其含量为每克膜30〜76mg 中间体,并在100〜180℃下加热膜中间体0.1〜360分钟。